Role of Functional Imaging in the Management of Lymphoma

被引:210
作者
Cheson, Bruce D. [1 ]
机构
[1] Georgetown Univ Hosp, Div Hematol Oncol, Washington, DC 20007 USA
关键词
POSITRON-EMISSION-TOMOGRAPHY; B-CELL LYMPHOMA; NON-HODGKINS-LYMPHOMA; HIGH-DOSE CHEMOTHERAPY; FDG-PET SCAN; COLONY-STIMULATING FACTOR; SUV-BASED ASSESSMENT; FOLLOW-UP; F-18; FLUORODEOXYGLUCOSE; PROGNOSTIC VALUE;
D O I
10.1200/JCO.2010.32.5225
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
18-F-fluorodeoxyglucose (FDG) -positron emission tomography (PET), and more recently PET/computed tomography (CT), is the most sensitive and specific imaging technique currently available for patients with lymphoma. Nevertheless, despite being increasingly used in pretreatment assessment, midtreatment evaluation of response, post-treatment restaging, and surveillance during follow-up of patients with lymphoma, its impact on clinical outcome in most clinical situations remains to be confirmed. PET/CT provides its greatest clinical benefit in the posttreatment evaluation of Hodgkin's lymphoma and diffuse large B-cell lymphoma; however, the role of metabolic imaging in other indications and in other histologies remains to be demonstrated. Ongoing risk-adapted studies will hopefully provide evidence for clinical improvement on the basis of altering treatment as a result of interim PET results. Efforts are ongoing to better standardize the conduct and interpretation of FDG-PET scans. FDG-PET has the potential to improve lymphoma patient management; however, its usefulness will likely vary by histology, stage, therapy, and clinical setting. J Clin Oncol 29: 1844-1854. (C) 2011 by American Society of Clinical Oncology
引用
收藏
页码:1844 / 1854
页数:11
相关论文
共 118 条
  • [21] Thallium-201 imaging in evaluation of Hodgkin's disease
    Dadparvar, S
    Hussain, R
    Esteves, F
    Yu, JQ
    Grewal, RK
    Arif, S
    Cruz, R
    Barbaria, CJ
    Woods, K
    Styler, MJ
    [J]. CANCER JOURNAL, 2002, 8 (06) : 469 - 475
  • [22] de Hemricourt Erard, 2003, Mol Imaging Biol, V5, P15, DOI 10.1016/S1536-1632(02)00123-3
  • [23] Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy
    Delcambre, C
    Reman, O
    Henry-Amar, M
    Peny, AM
    Macro, M
    Cheze, S
    Génot, JY
    Tanguy, A
    Switsers, O
    Van, HL
    Couëtte, JE
    Leporrier, M
    Bardet, S
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (02) : 176 - 184
  • [24] Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy
    Dickinson, Michael
    Hoyt, Rosemary
    Roberts, Andrew W.
    Grigg, Andrew
    Seymour, John F.
    Prince, H. Miles
    Szer, Jeff
    Ritchie, David
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (01) : 39 - 45
  • [25] Response assessment after an inductive CHOP or CHOP-like regimen with or without rituximab in 103 patients with diffuse large B-cell lymphoma: integrating 18fluorodeoxyglucose positron emission tomography to the International Workshop Criteria
    Dupuis, J.
    Itti, E.
    Rahmouni, A.
    Hemery, F.
    Gisselbrecht, C.
    Lin, C.
    Copie-Bergman, C.
    Belhadj, K.
    El Gnaoui, T.
    Gaillard, I.
    Kuhnowski, F.
    Meignan, M.
    Haioun, C.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (03) : 503 - 507
  • [26] Utility of FDG-PET scanning in lymphoma by WHO classification
    Elstrom, R
    Guan, L
    Baker, G
    Nakhoda, K
    Vergilio, JA
    Zhuang, H
    Pitsilos, S
    Bagg, A
    Downs, L
    Mehrotra, A
    Kim, S
    Alavi, A
    Schuster, SJ
    [J]. BLOOD, 2003, 101 (10) : 3875 - 3876
  • [27] Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma
    Elstrom, R. L.
    Leonard, J. P.
    Coleman, M.
    Brown, R. K. J.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (10) : 1770 - 1773
  • [28] Engert A, 2010, BLOOD, V116, P336
  • [29] SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY QUANTITATION OF GALLIUM CITRATE UPTAKE FOR THE DIFFERENTIATION OF LYMPHOMA FROM BENIGN HILAR UPTAKE
    EVENSAPIR, E
    BARSHALOM, R
    ISRAEL, O
    FRENKEL, A
    IOSILEVSKY, G
    HAIM, N
    EPELBAUM, R
    GAITINI, D
    KOLODNY, GM
    FRONT, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) : 942 - 946
  • [30] Fiore F, 2010, J CLIN ONCOL S, V28, p574s